Earth Science Tech, an expanding health-based holding company, recently announced the acquisition of Meduvo LLC, a compounding pharmacy that currently…
MS drug development is increasingly expanding beyond controlling inflammation toward approaches designed to protect the nervous system and address mechanisms…
Glioblastoma is very difficult to treat because it quickly adapts and evolves to become resistant to existing treatments indicated for…
Earth Science Tech seeks to implement a unified strategy aimed at maximizing shareholder value, resolving structural hurdles, and elevating corporate…
Researchers from the University of Manchester in the UK have found that a small group of immune cells that aren’t given much…
Regentis has passed 50% enrollment in the pivotal Phase III SAGE study of GelrinC, with recruitment completion targeted for the…
Dozens of global drugmakers are ramping up their investments in the United States in a bid to sidestep the planned tariffs on…
A new Japanese patent allowance follows a recent such US patent grant, strengthens protection around the organic solvent-free manufacturing process…
Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Researchers recognize that a large share of…
Beachgoers on the Gulf Coast in the U.S. have been urged to exercise caution in order to limit the risk of contracting a bacterial infection…